Skip to content

Screener

Eligibility screening

A Phase I/II Study of ITU512

Sponsored by Novartis PharmaceuticalsStudy detailsClinicalTrials.gov

1 US site in FL

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.